The trial won't be completed in Australia. The one here will be suspended probably early next year and a new trial run in the US or overseas.
Depending on how much the big investors in IBX lose Bob will either resign or move out of chair and/or CEO.
We can expect a very different safety trial to be completed by the end of 2022, and a larger trial in 2023.
IBX is cashed up for now, but will have burned/diluted $8-10m in this failed attempt at a trial. Will be a CR mid next year that is basically the same one run at 8.5c - to provide funds for the larger trial.
If you're holding and expecting the current trial to finish and get reported on early next year then you're dreaming.
